The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 2, 2005, Pages 203-210

  Chen, Wei Hsi ^a   Kao, Yi Fen ^a   Lan, Min Yu ^a   Chang, Yung Yee ^a   Chen, Shun Sheng ^a,b   Liu, Jia Shou ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anticardiolipin antibody; Atherosclerosis; Cerebral ischemia; Small artery occlusion

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; COOMBS TEST; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; EMBOLISM; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMORAL IMMUNITY; INTRACARDIAC THROMBOSIS; LARGE ARTERY ATHEROSCLEROTIC DISEASE; MALE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SMALL ARTERY OCCLUSIVE DISEASE; STROKE; TAIWAN;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SMOKING;

EID: 17444407818     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100210     Document Type: Article

References (36)

1. McIntyre JA, Wagenknecht DR, Faulk WP. Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog Lipid Res 2003;42:176.
2. Cuadrado MJ, Lopez-Pedrera C. Antiphospholipid syndrome. Clin Exp Med 2003;3:129.
3. Sherer Y, Shoenfeld Y. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiology 2003;207:13.
4. Ieko M. Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody [Jpn]. Rinsho Byori 2000;48:293.
5. Tuhrim S, Rand JH, Wu XX, et al. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 1999;30:1561.
6. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993;43:2069.
7. Zielinska J, Ryglewicz D, Wierzchowska E, Lechowicz W, Hier DB, Czlonkowska A. Anticardiolipin antibodies are an independent risk factor for ischemic stroke. Neurol Res 1999;21:653.
8. Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 2000;31:1289.
9. Adams HP Jr, Bendixen BH, Rappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis Rheum 1982;25:1271.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythrematosus [letter]. Arthritis Rheum 1997;40:1725.
12. Chen WH, Kao YF, Lan MY, Chang YY, Liu JS. A perturbation of antithrombin-III and protein C coupling associates with an increase of anti-beta2-glycoprotein I antibody in non-antiphospholipid antibody syndrome cerebral ischemia. Blood Coag Fibrinolysis 2002;13:703.
13. Chen WH, Lan MY, Chang YY, Chen SS, Liu JS. The prevalence of protein C, protein S and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia. Clin Appl Thromb/Hemost 2003;9:155.
14. Chen WH, Lui CC, Chen SS, Liu JS. An increase of blood anti-beta 2-glycoprotein-I antibody associates with cerebral hemorrhage in patients without antiphospholipid antibody syndrome. Int J Angiol (in press).
15. Montalban J, Rio J, Khamastha M, et al. Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke 1994;25:2412.
16. Chakravarty RK, Byron MA, Webley M, et al. Antibodies to cardiolipin and stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus. QJM 1991;79:397.
17. Metz LM, Edworthy S, Mydlarski R, Fritzler MJ. The frequency of phospholipid antibodies in an unselected stroke population. Can J Neurol Sci 1998;325:64.
18. Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000;31:3067.
19. Muir KW, Squire IB, Alwan W, Lees KR. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994;344:452.
20. Kitagawa Y, Okayasu H, Matsuoka Y, Mihara B, Koto A. Anticardiolipin antibody in cerebral infarction [Jpn]. Rinsho Shinkeigaku 1991;31:391.
21. Daif AK. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis. Funct Neurol 1998;13:285.
22. Nagaraja D, Christopher R, Manjari T. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience. J Neurol Sci 1997;150:137.
23. Wang PY, Leu TM, Tsai SJ, Tsay GJ. Anticardiolipin antibody in stroke. Chin Med J (Taipei) 1992;49:67.
24. Brey RL, Abbott RD, Curb JD, et al. Beta(2)-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu heart program. Stroke 2001;32:1701.
25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115.
26. Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31:256.
27. Salobir B, Sabovic M, Kozelj M. Increased levels of antiphospholipid antibodies in a woman with left atrial myxoma and systemic embolisms. Lupus 2001;10:815.
28. Sairam S, Baethge BA, McNearney T. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Clin Rheumatol 2003;22:24.
29. Chen WH. Anti-beta2-glycoprotein I antibody and hypertension in cerebral ischemia. Clin Appl Thromb/Hemost 2004;10:55.
30. Vaarala O. Accelerated atherosclerosis in antiphospholipid syndrome. In Khamashta MA, ed. Hughes syndrome. New York: Springer, 2000:172.
31. Ames PR, Margarita A, Delgado-Alves J, Tommasino C, Iannaccone L, Brancaccio V. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002;11:208.
32. George J, Afek A, Gilburd B, et al. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997;6:723.
33. Koike T. Antiphospholipid antibodies in arterial thrombosis. Ann Med 2000;32 Suppl 1:27.
34. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275.
35. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40:1190.
36. Tsai MH, Tsai WP, Liao ST, Liou LB. Anticardiolipin antibodies in various diseases in Taiwan: A retrospective analysis. Lupus 2003;12:747.